[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.108.121. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,377
Citations 0
Correction
October 27, 2015

Clarification of Author Affiliation

JAMA. 2015;314(16):1753. doi:10.1001/jama.2015.12980

In the In Reply letter entitled “FDA Expanded Access Programs for Experimental Medicines” published in the September 22/29, 2015, issue of JAMA,1 the author affiliation for Mr Kuhlik is incorrect. The author affiliations should read, “Merck, Kenilworth, New Jersey (Rosenblatt); Formerly with Merck (Kuhlik).” This article was corrected online.

References
1.
Rosenblatt  M, Kuhlik  B.  FDA expanded access programs for experimental medicines. JAMA. 2015;314(12):1296.Article
×